Elevance Health, Inc. (ELV) News
Track canonical SquawkNews coverage tagged to ELV, Elevance Health, Inc.. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 54 indexed stories across 22 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Americans navigate 'wild West' of health insurance options after dropping Obamacare plans
By Sriparna RoyWhen Stacy Cox, a self-employed photographer in Kanab, Utah, dropped her Obamacare health insurance plan this year, routine preventive care became a financial dilemma. Now she finds herself weighing $1,200
NEWS | Sep 25, 2026, 10:00 AM UTC
L
Elevance leads UBS health benefits survey as employers brace for higher costs
Elevance Health emerged as the highest-rated national health insurer in UBS’s annual survey of employee-benefit managers, while the three largest pharmacy-benefit managers appear well positioned to withstand a surge in c
NEWS | Sep 13, 2026, 06:01 PM UTC
H
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Wall Street rallied on Friday after the latest consumer inflation report came in broadly in line with expectations, helping ease concerns over price pressures and supporting a rebound across risk assets.On Friday, the Do
NEWS | Sep 13, 2026, 01:11 PM UTC
M
Elevance Health reaffirms FY26 earnings guidance
Elevance Health said it is standing by its full-year 2026 adjusted earnings floor of $20.10 per diluted share ahead of investor meetings. It also kept its adjusted earnings outlook above $27.00 per share and its benefit
EARNINGS | Sep 10, 2026, 06:13 PM UTC
H
Elevance Health reaffirms FY26 GAAP and adjusted EPS guidance
EARNINGS | Sep 10, 2026, 02:11 PM UTC
H
ELV reaffirms 2026 EPS guidance; targets 12%+ 2027 growth
Management reaffirmed 2026 EPS guidance and expects at least 12% EPS growth in 2027. The company attributes the outlook to execution, favorable cost trends, disciplined investments in AI and Carelon, and strong performan
EARNINGS | Sep 10, 2026, 01:28 PM UTC
H
ELV reaffirms 2026 EPS guidance; expects 12%+ EPS growth in 2027
Elevance management reaffirmed 2026 EPS guidance and expects at least 12% EPS growth in 2027. The company cited strong execution across Medicare Advantage, Medicaid and Carelon, with AI and targeted investments supportin
EARNINGS | Sep 10, 2026, 12:59 PM UTC
L
25 dividend stocks to watch as market sentiment turns negative
Dividend-paying stocks gained renewed momentum Wednesday as investors shifted toward safety amid a slide in broader market averages.The blue-chip Dow Jones Industrial Average TVC:DJI dropped to a new one-month low while
ENERGY | Sep 09, 2026, 04:51 PM UTC
L
Elevra Lithium announces pre-feasibility study results for NAL expansion
Elevra Lithium Limited says it has published results of a Pre-Feasibility Study for the staged North American Lithium (NAL) Brownfield Expansion, with details described as in Q…
EQUITY | Sep 08, 2026, 08:37 PM UTC
M
ELV: Elevra expansion projects fully funded for capacity growth
Elevra says its NAL and Moblan expansion projects are fully funded, targeting significant capacity growth, and cites North America’s largest hard-rock lithium resource base and major producer operations.
EQUITY | Sep 07, 2026, 10:46 PM UTC
M
Elevra Lithium estimates life-of-mine AISC at C$918/ton post-expansion
Elevra Lithium estimates life-of-mine AISC post-expansion at C$918/ton.
EQUITY | Sep 06, 2026, 10:32 PM UTC
L
Elevra Lithium PFS confirms expansion capex of C$366 million
Elevra Lithium’s PFS confirms expansion capital expenditure of C$366 million.
EQUITY | Sep 06, 2026, 10:31 PM UTC
M
Elevra Lithium expansion targets 373,000-ton average annual output
Elevra Lithium says its North American expansion is set to lift average annual output to 373,000 tons.
EQUITY | Sep 06, 2026, 10:29 PM UTC
L
Macquarie cuts Elevra Lithium target price 5.7% to A$12.50
Macquarie cut Elevra Lithium’s target price by 5.7% to A$12.50 a share.
EQUITY | Aug 31, 2026, 12:07 AM UTC
H
Elevra Lithium targets FY27 capex of $120M–$140M
Elevra Lithium says FY27 capital expenditures will be $120 million to $140 million.
EARNINGS | Aug 28, 2026, 01:30 AM UTC
H
ELV: Strong revenue growth, merger synergies, and fully funded expansion drive positive outlook
ELV: Strong revenue growth, merger synergies, and fully funded expansion drive positive outlook
EARNINGS | Aug 27, 2026, 10:13 PM UTC
M
ELV reports first full-year profit
ELV says it delivered its first full-year profit, attributing results to higher lithium prices, merger synergies, and robust cash flows.
MNA | Aug 27, 2026, 10:11 PM UTC
L
Elevra Lithium will not pay a final dividend
Elevra Lithium says it will not pay a final dividend.
EQUITY | Aug 27, 2026, 10:00 PM UTC
L
Elevra Lithium FY revenue A$201.7 million, up 39%
Elevra Lithium reported FY revenue of A$201.7 million, up 39% year over year.
EQUITY | Aug 27, 2026, 10:00 PM UTC
L
Elevra Lithium reports FY net profit of A$43.1 million
Elevra Lithium said its FY net profit was A$43.1 million.
EQUITY | Aug 27, 2026, 10:00 PM UTC
H
ELV faces EPS decline in 2026, per Argus
Hammerstone MarketTalk says ELV is facing an EPS decline in 2026 at Argus, but provides no EPS level, magnitude, or catalyst in the alert.
EARNINGS | Aug 21, 2026, 12:57 PM UTC
L
CDW, Elevance, Omnicom hit highs
CDW, Elevance Health and Omnicom are hitting highs, with no catalyst or magnitude supplied in the feed.
EQUITY | Aug 19, 2026, 05:43 PM UTC
L
HUM CI UNH ELV The Trump administration plans to end a subsidy program that helped hold down premiums for Medicare drug plans, a move that c
HUM CI UNH ELV The Trump administration plans to end a subsidy program that helped hold down premiums for Medicare drug plans, a move that could leave many seniors facing higher rates for their prescription coverage next
GEOPOLITICS | Jul 28, 2026, 08:00 PM UTC
L
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - TSLA -8.75%, AMZN - 0.16%, NCLH +0.36%, CVNA +0.56%, DASH +
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - TSLA -8.75%, AMZN - 0.16%, NCLH +0.36%, CVNA +0.56%, DASH +0.64% Consumer Staples (XLP) - DG -2.81%, EL -2.72%, KR -2.15%, DLTR -2.06%, GIS
RATES | Jul 23, 2026, 04:00 PM UTC
L
ELV Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 Link To Filing
ELV Elevance Health CEO Gail Boudreaux acquires common shares worth $1,003,428.45 Link To Filing
EQUITY | Jul 17, 2026, 06:01 PM UTC
H
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
UnitedHealth Group (NYSE: UNH ) surged about 9% in premarket trading Thursday after raising its full-year earnings guidance, despite reporting a loss of 965,000 Medicare Advantage members since the end of 2025. The move
RATES | Jul 16, 2026, 05:24 PM UTC
H
Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It
Starting in December 2026, millions of Medicaid enrollees will have to prove they still qualify twice as often as they do today, and the Urban Institute estimates the change could push 2 to 3.1 million people out of the
EARNINGS | Jul 16, 2026, 01:24 PM UTC
L
ELV PT raised from $399 to $455, maintains Buy @ GUGG
ELV PT raised from $399 to $455, maintains Buy @ GUGG
EQUITY | Jul 16, 2026, 12:56 PM UTC
H
These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported upbeat second-quarter results and raised its full-year guidance. Adjusted earnings came in at $7.45 per share, beating the analyst consensus estimate of $6.21. Reve
EARNINGS | Jul 16, 2026, 12:17 PM UTC
H
Sector Update: Healthcare Stocks Advance Late Afternoon
() -- Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.1%. The iShares Biotechnology ETF (IBB) added 0
EARNINGS | Jul 15, 2026, 07:47 PM UTC
H
Top Midday Decliners
() -- Pentair (PNR) reported preliminary Q2 results below market estimates and lowered its full-year outlook amid headwinds related to its pool segment. Pentair CFO Nick Brazis' unexpected departure, just four months aft
EARNINGS | Jul 15, 2026, 06:40 PM UTC
L
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - ORLY -3.68%, YUM -3.53%, CMG -3.12%, AZO -2.27%, GPC - 2.08
Underperformers vs S&P sector ETFs (% chg vs ETF) Consumer Discretionary (XLY) - ORLY -3.68%, YUM -3.53%, CMG -3.12%, AZO -2.27%, GPC - 2.08% Consumer Staples (XLP) - MKC -3.39%, CASY -3.31%, KR -3.23%, SYY -2.79%, BG -
RATES | Jul 15, 2026, 06:23 PM UTC
H
Sector Update: Healthcare Stocks Advance in Afternoon Trading
() -- Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index adding 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.3%. The iShares Biotechnology ETF (IBB) added 0.3%.
EARNINGS | Jul 15, 2026, 05:41 PM UTC
H
Top Midday Stories: PayPal Reportedly Gets Acquisition Offer From Stripe, Advent; ASML Misses Q2 EPS, Sales Estimates, Lifts Outlook
() -- All three major US stock indexes were up in late-morning trading Wednesday, as technology stocks led the way up and additional inflation data showed further cooling. The US Producer Price Index fell by 0.3% in June
MACRO | Jul 15, 2026, 03:50 PM UTC
H
Elevance Second-Quarter Membership Declines Overshadow Full-Year Earnings Outlook Raise
() -- Elevance Health (ELV) reported sequential and annual declines in its second-quarter memberships, although the health insurer lifted its full-year earnings outlook and recorded an unexpected year-over-year revenue i
EARNINGS | Jul 15, 2026, 03:43 PM UTC
H
Elevance Health's Small Outlook Boost Disappoints, Stock Sinks
Elevance Health Inc. (NYSE: ELV ) on Wednesday reported second-quarter results that topped Wall Street estimates and raised its full-year adjusted earnings and operating cash flow guidance, supported by higher premium yi
EARNINGS | Jul 15, 2026, 02:22 PM UTC
L
ELV Elevance health exec notes Co is seeing moderately lower Surgery trends in medicare and obamacare plans- conf call
ELV Elevance health exec notes Co is seeing moderately lower Surgery trends in medicare and obamacare plans- conf call
RATES | Jul 15, 2026, 01:27 PM UTC
H
Sector Update: Healthcare Stocks Decline Premarket Wednesday
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.6% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were d
EARNINGS | Jul 15, 2026, 01:16 PM UTC
H
Sector Update: Healthcare
() -- Healthcare stocks were declining premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4% and the iShares Biotechnology ETF (IBB) 0.1% lower. Elevance Health (ELV) shares were d
EARNINGS | Jul 15, 2026, 12:59 PM UTC
H
Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Nasdaq 100 futures gaining around 100 points on Wednesday. Shares of Phoenix Education Partners Inc (NYSE: PXED ) fell sharply in pre-market trading after the
EARNINGS | Jul 15, 2026, 12:02 PM UTC
L
MOH -6% CNC -4% OSCR -1.5% premarket after ELV results, -7.5%
MOH -6% CNC -4% OSCR -1.5% premarket after ELV results, -7.5%
EQUITY | Jul 15, 2026, 11:20 AM UTC
H
Earnings Calendar: • Earnings Before the Open: ASML BLK BNY CAG CTAS ELV FHN JNJ MS MTB PGR PNC SIFY • Earnings After the Close: GSBC HOMB J
Earnings Calendar: • Earnings Before the Open: ASML BLK BNY CAG CTAS ELV FHN JNJ MS MTB PGR PNC SIFY • Earnings After the Close: GSBC HOMB JBHT KARO UAL
EARNINGS | Jul 15, 2026, 10:50 AM UTC
H
ELV Elevance Health RESULTS: Q2, Q2 operating REV $49.800B, Q2 EPS $6.71, Q2 ADJ EPS $7.45 vs. EST $6.21, Q2 benefit expense ratio 89.7%, El
ELV Elevance Health RESULTS: Q2, Q2 operating REV $49.800B, Q2 EPS $6.71, Q2 ADJ EPS $7.45 vs. EST $6.21, Q2 benefit expense ratio 89.7%, Elevance Health Earnings Notes:, Outlook FY EPS $20.1, Outlook FY ADJ EPS $27 vs.
RATES | Jul 15, 2026, 10:26 AM UTC
H
Elevance Health Q2 Adjusted Earnings Fall, Revenue Rises; Raises Full-Year Adjusted EPS Outlook
() -- Elevance Health (ELV) reported Q2 adjusted earnings Wednesday of $7.45 per diluted share, down from $8.84 a year earlier. Analysts polled by FactSet expected $6.21. Operating revenue for the quarter ended June 30 w
EARNINGS | Jul 15, 2026, 10:17 AM UTC
L
Elevance Health raises FY26 adjusted EPS view to 'at least $27.00'
Prior view was FY26...
EARNINGS | Jul 15, 2026, 10:03 AM UTC
L
Elevance Health reports Q2 adjusted EPS $7.45, consensus $6.21
Reports Q2 revenue...
EQUITY | Jul 15, 2026, 10:02 AM UTC
H
Earnings Flash (ELV) Elevance Health, Inc. Reports Q2 Revenue $49.83B, vs. FactSet Est of $48.84B
() -- Copyright © 2026. All rights reserved. does not provide investment advice. Unauthorized reproduction is strictly prohibited.
EQUITY | Jul 15, 2026, 10:00 AM UTC
L
UNH CI ELV AGL PRVA ASTH CMS Proposes Transformational Medicare Reforms to Expand Accountable Care, Modernize Physician Payment, and Shift f
UNH CI ELV AGL PRVA ASTH CMS Proposes Transformational Medicare Reforms to Expand Accountable Care, Modernize Physician Payment, and Shift from Sick Care to Healthcare -The Centers for Medicare & Medicaid Services (CMS)
EQUITY | Jul 14, 2026, 08:45 PM UTC
L
Implied EPS Movers for Tomorrow AM: SIFY +/-16.32%, PNC +/-3.12%, PGR 3.04%, MTB +/-3.48%, MS +/-3.90%, JNJ +/-2.95%, FHN +/-3.34%, ELV +/-5
Implied EPS Movers for Tomorrow AM: SIFY +/-16.32%, PNC +/-3.12%, PGR 3.04%, MTB +/-3.48%, MS +/-3.90%, JNJ +/-2.95%, FHN +/-3.34%, ELV +/-5.70%, CTAS +/-3.88%, CAG +/-4.97%, BNY +/-4.02%, BLK +/-3.74%, ASML +/-6.51%
EARNINGS | Jul 14, 2026, 06:49 PM UTC
L
Elevance Health price target raised by $25 at Truist, here's why
Elevance Health price target raised by $25 at Truist, here's why
EQUITY | Jul 14, 2026, 11:50 AM UTC
H
Elevance Health price target raised to $439 from $358 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm's price target on Elevance Health to $439 from $358 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Healthcare
EQUITY | Jul 09, 2026, 12:13 PM UTC
H
Elevance Health price target raised to $450 from $400 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm's price target on Elevance Health to $450 from $400 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, suppo
EQUITY | Jul 07, 2026, 11:09 AM UTC
L
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit
Elevance Health Inc. (NYSE: ELV ) has sued the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), alleging the agencies unlawfully applied different standards to Me
GEOPOLITICS | Jul 06, 2026, 02:02 PM UTC
M
PSTV: Strikes Deal
CNSide Diagnostics, a subsidiary of Plus Therapeutics, strikes deal with Elevance Health to offer CNSide Cerebrospinal Fluid Tumor Cell Enumeration Assay
EQUITY | Jun 25, 2026, 11:35 AM UTC